IL117551A0
(en )
1996-07-23
Nanosuspensions for intravenous administration
GB2301537B
(en )
1998-02-25
Two-component device for the administration of drugs
AU6048696A
(en )
1996-12-30
Fluorochemical solutions for the delivery of lipophilic phar maceutical agents
IL125111A0
(en )
1999-01-26
Medical intravenous administration line connector
AU1683995A
(en )
1995-08-08
Intravenous administration of psoralen
AU5652098A
(en )
1998-08-25
A device for the administration of a liquid medicament suspension
HU9900879D0
(en )
1999-05-28
Reverse fluorocarbon emulsion compositions for drug delivery
AU3432993A
(en )
1993-09-01
Pouch for administering medical fluids
IS2537B
(en )
2009-08-15
Medicinal product for intravenous administration
HUP0000474A3
(en )
2001-06-28
Arylethenesulfonamide derivatives and drug composition containing the same
AU6410494A
(en )
1994-10-11
Device for the transdermal administration of alprazolam
GB9601186D0
(en )
1996-03-20
Administration of Drugs
GB9524880D0
(en )
1996-02-07
Fluid administration apparatus
AU1189392A
(en )
1992-09-07
Pharmaceutical agent
GB2308067B
(en )
1999-03-10
Fluid administration
ZA967815B
(en )
1997-04-07
Nanodispersions for the intravenous administration of an aneasthetic agent having lipophilic properties
AU8614291A
(en )
1992-05-20
Device for administering drugs
AU3725895A
(en )
1996-05-02
Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent
GB9222591D0
(en )
1992-12-09
Medicinal remedy
ZA945651B
(en )
1996-01-29
Use of benzenesulphonzlindole derivatives for the preparation of medicines
GB9304549D0
(en )
1993-04-21
Apparatus for administration of drugs
AU4292993A
(en )
1993-11-29
Improved delivery formulation for lipophilic drugs
GB9027358D0
(en )
1991-02-06
Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
GB9027367D0
(en )
1991-02-06
Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
GB9027402D0
(en )
1991-02-06
Agents for potentiating the effects of antitumor agents and combating multiple drug resistance